Targeting the Th17/Treg axis: from immunological insights to therapeutic avenues in atherosclerosis

Zhang Qin, Siqing Chen, Zhe Lyu, Fengyun Zhou, Le Liu, Qi Ai, Zhuo Zeng

Open source

DOI
10.3389/fimmu.2026.1923083
Published
2026-09-10
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1923083,
  title = {Targeting the Th17/Treg axis: from immunological insights to therapeutic avenues in atherosclerosis},
  author = {Zhang Qin and Siqing Chen and Zhe Lyu and Fengyun Zhou and Le Liu and Qi Ai and Zhuo Zeng},
  year = {2026},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2026.1923083},
  url = {https://doi.org/10.3389/fimmu.2026.1923083}
}

RIS

TY  - JOUR
TI  - Targeting the Th17/Treg axis: from immunological insights to therapeutic avenues in atherosclerosis
AU  - Zhang Qin
AU  - Siqing Chen
AU  - Zhe Lyu
AU  - Fengyun Zhou
AU  - Le Liu
AU  - Qi Ai
AU  - Zhuo Zeng
PY  - 2026
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1923083
UR  - https://doi.org/10.3389/fimmu.2026.1923083
ER  - 

APA

Qin, Z., Chen, S., Lyu, Z., Zhou, F., Liu, L., Ai, Q., & Zeng, Z. (2026). Targeting the Th17/Treg axis: from immunological insights to therapeutic avenues in atherosclerosis. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1923083

Source records